JB Chemicals & Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	JB Chem & Pharma	Astrazeneca Pharma I	Pfizer
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	19.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	17.0 .	n/a	n/a
Domestic Sales Growth - YoY	10.1 %	18.6 %	4.8 %
R&D as a % of Total Sales	1.35 %	0.0	n/a
Financials
5 yr Average ROE	19.49 %	17.42 %	19.03 %
5yr average Equity Multiplier	1.52	1.99	1.25
5yr Average Asset Turnover Ratio	0.77	0.91	0.6
5yr Avg Net Profit Margin	16.71 %	9.65 %	26.04 %
Price to Book	7.66	30.95	5.65
P/E	38.4	130.01	29.46
5yr Avg Cash Conversion Cycle	7.58 Days	-6.33 Days	21.86 Days
Inventory Days	50.33 Days	68.19 Days	49.93 Days
Days Receivable	67.54 Days	35.81 Days	29.1 Days
Days Payable	90.39 Days	187.52 Days	77.28 Days
5yr Average Interest Coverage Ratio	58.81	142.38	185.18
5yr Avg ROCE	23.05 %	23.84 %	23.84 %
5yr Avg Operating Profit Margin	24.73 %	14.57 %	31.72 %
5 yr average Debt to Equity	0.07	0.0	0.0
5yr CAGR Net Profit	8.05 %	4.4 %	76.68 %
5yr Average Return on Assets	12.98 %	8.92 %	15.25 %
Shareholdings
Promoter Holding	47.56 %	75.0 %	63.92 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.4 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	3.75 %	3.91 %	5.23 %

	JB Chem & Pharma	Astrazeneca Pharma I	Pfizer
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 61.97 Formulations 25.87 Contract Manufacturing 10.51 Active Pharmaceutical Ingredient (API) 1.65 Clinical trials 0 Pharmaceutical products 0 Pharmaceutical 0	Product Wise Break-Up Contract Manufacturing 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 93.72 Pharmaceutical 0 Domestic Formulations 0 Formulations 0 Clinical Trial 6.11 Others 0.17	Product Wise Break-Up Contract Manufacturing 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical products 0 Pharmaceutical 100.0 Domestic Formulations 0 Formulations 0 Clinical trials 0
Location Wise Break-Up	Location Wise Break-Up India 57.91 Rest of the World 42.09 Russia 0 South Africa 0 USA 0	Location Wise Break-Up USA 0 India 93.61 South Africa 0 Rest of the World 6.39 Russia 0	Location Wise Break-Up USA 0 India 95.0 South Africa 0 Rest of the World 5.0 Russia 0
Customer Wise Break-Up	Customer Wise Break-Up THINQ PHARMA-CRO PVT LTD 7.83 Others 92.17	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 96.32 Others 3.68	-	-